Pasithea Therapeutics Corp. (KTTAW) Assets Average (2021 - 2026)

Pasithea Therapeutics has disclosed Assets Average across 6 years of filings, most recently posting $54.0 million for Q2 2026.

• In Q2 2026, Assets Average rose 241.24% year-over-year to $54.0 million; the TTM figure through Jun 2026 stood at $54.0 million (up 241.24% YoY), while the FY2025 annual figure was $38.2 million, up 80.9% from the prior year.
• Assets Average came in at $54.0 million for Q2 2026 at Pasithea Therapeutics, down from $58.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $58.3 million in Q1 2026 to a low of $15.3 million in Q3 2025.
• Average Assets Average over 5 years is $34.7 million, with a median of $35.7 million recorded in 2023.
• Year-over-year, Assets Average tumbled 50.03% in 2024 and surged 279.5% in 2026.
• Over 5 years, Assets Average stood at $47.4 million in 2022, then tumbled by 40.1% to $28.4 million in 2023, then plunged by 38.88% to $17.4 million in 2024, then surged by 112.87% to $36.9 million in 2025, then soared by 46.29% to $54.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $54.0 million in Q2 2026, $58.3 million in Q1 2026, and $36.9 million in Q4 2025.